ERBB2 and neoplasm: These were directed against tumor associated antigens such as human epidermal growth factor receptor (EGFR), epithelial cell adhesion molecule (EpCAM) and human epithelial growth factor receptor 2 (HER2), thereby retargeting Ovs to recognize a variety of tumor cell types (147–150).